Results 41 to 50 of about 1,473,215 (222)

European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes [PDF]

Journal of the European Academy of Dermatology and Venereology, 2017
Robert Knobler, Pia Moinzadeh, Nicolas Hunzelmann, Alexander Kreuter, Antonio Cozzio, Luc Mouthon, Maurizio Cutolo, Franco Rongioletti, Christopher P. Denton, Lidia Rudnicka, L.A. Frasin, Vanessa Smith, Tianlu Li, Elisabeth Aberer, M. Bagot, G. Bali, Jean‐David Bouaziz, Anne Braae Olesen, Ivan Foeldvari, C. Françès, Ahmad Jalili, Ulrike Just, Veli‐Matti Kähäri, Sarolta Kárpáti, Klaus F. Kofoed, Dorota Krasowska, Małgorzata Olszewska, Catherine H. Orteu, Jaana Panelius, Aurora Parodi, A. Petit, Pietro Quaglino, Annamari Ranki, J Schmidt, Julien Sénéschal, Anna Skrok, Michael Sticherling, Cord Sunderkötter, Alain Taı̈eb, Adrian Tanew, Peter Wolf, Margitta Worm, Nora Wutte, Thomas Krieg   +43 more
openalex   +2 more sources

Localized scleroderma – current treatment options

Przegląd Dermatologiczny, 2017
Localized scleroderma (morphea) is a connective tissue disease that affects the skin, subcutaneous tissue and underlying tissues including the fasciae, muscles and bones. The treatment of localized scleroderma depends on the clinical form of the disease,
Katarzyna Wolska-Gawron, Małgorzata Michalska-Jakubus, Dorota Krasowska   +2 more
doaj   +1 more source

DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma. [PDF]

Clin Immunol, 2021
Coit P, Schollaert KL, Mirizio EM, Torok KS, Sawalha AH.   +4 more
europepmc   +2 more sources

Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy

Journal of Cutaneous Immunology and Allergy, 2022
A 47‐year‐old woman with mixed connective tissue disease was treated with abatacept. After 2 months, a 3‐cm depression with atrophied surface was observed on her back, which had histopathological consistent with the symptoms of localized scleroderma ...
Sayuko Nagaoka, Shujiro Hayashi, Ken Igawa   +2 more
doaj   +1 more source

Association between Localized Scleroderma Cutaneous Assessment Tool and clinicopathologic characteristics in patients with morphea

Turkderm Turkish Archives of Dermatology and Venereology, 2022
Background and Design: Morphea is also known as localized scleroderma. It is a rare autoimmune skin disease characterized by inflammation and sclerosis in the dermis and sometimes in the subcutaneous tissue.
Yıldız Gürsel Ürün, Elif Usturalı Keskin   +1 more
doaj   +1 more source

Hyperpigmented lesions with acquired atrophy following Blaschko lines in a patient with diagnosed with localized scleroderma

Boletín Médico del Hospital Infantil de México, 2021
Background: Linear atrophoderma of Moulin (LAM) is a dermatosis that affects children and adolescents characterized by hyperpigmented and atrophic linear lesions following Blaschko lines. So far, less than 50 cases have been published. Therefore, it is a
Eduardo Marín-Hernández, Belén Suárez-Frías, Alicia G. Siordia Reyes   +2 more
doaj   +1 more source

Localized scleroderma: A rare clinical entity

Journal of Indian Academy of Oral Medicine and Radiology, 2014
Localized Scleroderma (LS), which is also referred to as morphea, is an inflammatory disease that leads to diffuse or localized fibrotic and atrophic skin hardening.
Ranjana Garg, Swati Dhingra, Ravneet Arora   +2 more
doaj   +1 more source

The Plastic Surgery for Localized Scleroderma: Progress in Diagnosis and Treatment and Opinions from Peking Union Medical College Hospital

Xiehe Yixue Zazhi, 2022
Localized scleroderma is a rare auto-immune disorder characterized by inflammation and fibrosis of the skin and subcutaneous fat in the affected area, leaving aesthetic impairment to the patients.Such patients often seek plastic surgery for the treatment.
WANG Chenyu, LONG Xiao, ZENG Ang, HUANG Jiuzuo, WANG Xiaojun   +4 more
doaj   +1 more source

Frequency of occurrenceof tumor-associated localized scleroderma

Лечащий Врач
Background. Tumor-associated localized scleroderma is observed among patients with localized scleroderma. It is assumed that the development of this condition may be facilitated by both the inflammatory processes in scleroderma and oncological processes ...
P. O. Kazakova
doaj   +1 more source

S2k guideline: Diagnosis and therapy of localized scleroderma

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
The updated S2k guideline deals with the diagnosis and therapy of localized scleroderma (LoS). LoS represents a spectrum of sclerotic skin diseases in which, depending on the subtype and localisation, structures such as adipose tissue, muscles, joints ...
A. Kreuter, P. Moinzadeh, M. Kinberger, G. Horneff, M. Worm, R. N. Werner, Andreas Hammacher, T. Krieg, Jörg Wenzel, Michael Oeschger, L. Weibel, R. Müllegger, N. Hunzelmann   +12 more
semanticscholar   +1 more source